Hypoxaemia in chronic obstructive bronchitis.

Por Middleton, H C, Peake, M D, Howard, P
Publicado em 1979

Comparison of salbutamol given by intermittent positive-pressure breathing and pressure-packed aerosol in chronic asthma.

Por Anderson, P B, Goude, A, Peake, M D
Publicado em 1982

The accuracy of a pharmacokinetic theophylline predictor using once daily dosing.

Por Chrystyn, H, Mulley, B A, Peake, M D
Publicado em 1987

Dose response relation to oral theophylline in severe chronic obstructive airways disease.

Por Chrystyn, H., Mulley, B. A., Peake, M. D.
Publicado em 1988

Response to oral theophylline in severe chronic obstructive airways disease: Authors' reply

Por Peake, M D, Chrystyn, H, Mulley, B A
Publicado em 1989

Responses of consecutive patients to reassurance after gastroscopy: results of self administered questionnaire survey.

Por Lucock, M. P., Morley, S., White, C., Peake, M. D.
Publicado em 1997

Familial malignant retroperitoneal paraganglioma.

Por Sebastian, J. P., Williams, S. E., Wells, M., Peake, M. D.
Publicado em 1989

Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.

Por Chrystyn, H, Ellis, J W, Mulley, B A, Peake, M D
Publicado em 1989

A multicentre randomised controlled trial of reciprocal lung cancer peer review and supported quality improvement: results from the improving lung cancer outcomes project

Por Russell, G K, Jimenez, S, Martin, L, Stanley, R, Peake, M D, Woolhouse, I
Publicado em 2014

An evaluation of the impact of large-scale interventions to raise public awareness of a lung cancer symptom

Por Ironmonger, L, Ohuma, E, Ormiston-Smith, N, Gildea, C, Thomson, C S, Peake, M D
Publicado no Br J Cancer (2015)

Modelling the cost-effectiveness of public awareness campaigns for the early detection of non-small-cell lung cancer

Por Hinde, S, McKenna, C, Whyte, S, Peake, M D, Callister, M E J, Rogers, T, Sculpher, M
Publicado no Br J Cancer (2015)

Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer.

Por Cooper, E. H., Splinter, T. A., Brown, D. A., Muers, M. F., Peake, M. D., Pearson, S. L.
Publicado em 1985

Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: results of a feasibility study

Por Anderson, H, Addington-Hall, J M, Peake, M D, McKendrik, J, Keane, K, Thatcher, N
Publicado em 2003

How do patient and hospital features influence outcomes in small-cell lung cancer in England?

Por Rich, A L, Tata, L J, Free, C M, Stanley, R A, Peake, M D, Baldwin, D R, Hubbard, R B
Publicado em 2011

Lung cancer referral patterns in the former Yorkshire region of the UK

Por Melling, P P, Hatfield, A C, Muers, M F, Peake, M D, Storer, C J, Round, C E, Haward, R A, Crawford, S M
Publicado em 2002

A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer

Por Johnson, P W M, Muers, M F, Peake, M D, Poulter, K M, Gurney, E M, Napp, V, Hepburn, P M, Brown, J M
Publicado em 2001